These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30518936)

  • 1. Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16.
    Sagwal SK; Pasqual-Melo G; Bodnar Y; Gandhirajan RK; Bekeschus S
    Cell Death Dis; 2018 Dec; 9(12):1179. PubMed ID: 30518936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction.
    Gandhirajan RK; Rödder K; Bodnar Y; Pasqual-Melo G; Emmert S; Griguer CE; Weltmann KD; Bekeschus S
    Sci Rep; 2018 Aug; 8(1):12734. PubMed ID: 30143716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
    Dong YB; Yang HL; Elliott MJ; McMasters KM
    Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the organic cation transporter SLC22A16: a doxorubicin importer.
    Okabe M; Unno M; Harigae H; Kaku M; Okitsu Y; Sasaki T; Mizoi T; Shiiba K; Takanaga H; Terasaki T; Matsuno S; Sasaki I; Ito S; Abe T
    Biochem Biophys Res Commun; 2005 Aug; 333(3):754-62. PubMed ID: 15963465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of organic cation transporter SLC22A16 in human epithelial ovarian cancer: a possible role of the adriamycin importer.
    Ota K; Ito K; Akahira J; Sato N; Onogawa T; Moriya T; Unno M; Abe T; Niikura H; Takano T; Yaegashi N
    Int J Gynecol Pathol; 2007 Jul; 26(3):334-40. PubMed ID: 17581421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of cold atmospheric pressure plasma and free or liposomal doxorubicin on melanoma cells.
    Pefani-Antimisiari K; Athanasopoulos DK; Marazioti A; Sklias K; Rodi M; de Lastic AL; Mouzaki A; Svarnas P; Antimisiaris SG
    Sci Rep; 2021 Jul; 11(1):14788. PubMed ID: 34285268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
    Sochanik A; Mitrus I; Smolarczyk R; Cichoń T; Snietura M; Czaja M; Szala S
    Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
    Buß I; Hamacher A; Sarin N; Kassack MU; Kalayda GV
    Metallomics; 2018 Mar; 10(3):414-425. PubMed ID: 29417972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold atmospheric helium plasma causes synergistic enhancement in cell death with hyperthermia and an additive enhancement with radiation.
    Moniruzzaman R; Rehman MU; Zhao QL; Jawaid P; Takeda K; Ishikawa K; Hori M; Tomihara K; Noguchi K; Kondo T; Noguchi M
    Sci Rep; 2017 Sep; 7(1):11659. PubMed ID: 28916738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-thermal plasma-induced apoptosis is modulated by ATR- and PARP1-mediated DNA damage responses and circadian clock.
    Choi JY; Joh HM; Park JM; Kim MJ; Chung TH; Kang TH
    Oncotarget; 2016 May; 7(22):32980-9. PubMed ID: 27145275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of organic cation transporter SLC22A16 in human endometria.
    Sato N; Ito K; Onogawa T; Akahira J; Unno M; Abe T; Niikura H; Yaegashi N
    Int J Gynecol Pathol; 2007 Jan; 26(1):53-60. PubMed ID: 17197897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin.
    Hammouda MB; Riahi-Chebbi I; Souid S; Othman H; Aloui Z; Srairi-Abid N; Karoui H; Gasmi A; Magnenat EM; Wells TNC; Clemetson KJ; Rodríguez-López JN; Essafi-Benkhadir K
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):600-614. PubMed ID: 29196192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
    Chiu SJ; Lee YJ; Hsu TS; Chen WS
    Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition.
    Deng Y; Li F; He P; Yang Y; Yang J; Zhang Y; Liu J; Tong Y; Li Q; Mei X; Shu Z; Zhao Q
    Mol Carcinog; 2018 Jun; 57(6):807-814. PubMed ID: 29500880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib antagonizes the cytotoxicity of oxaliplatin in human esophageal cancer cells by impairing the drug influx.
    Kong Y; Gu C; Zhong D; Zhao X; Lin Q; Wang K; Xun T; Yu L; Liu S
    Eur J Pharm Sci; 2016 Jan; 81():137-48. PubMed ID: 26474693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer.
    Bakkenist CJ; Lee JJ; Schmitz JC
    Clin Colorectal Cancer; 2018 Dec; 17(4):255-257. PubMed ID: 30316683
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined Application of Cold Physical Plasma and Chemotherapeutics against Chondrosarcoma Cells.
    Nitsch A; Qarqash S; Schulze F; Nonnenmacher L; Bekeschus S; Tzvetkov MV; Wassilew GI; Haralambiev L
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer.
    Zhao W; Wang Y; Yue X
    Future Oncol; 2018 Sep; 14(21):2139-2148. PubMed ID: 29698084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
    Wu CL; Ping SY; Yu CP; Yu DS
    Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.